Optimization of Human Dose Prediction by Using Quantitative and Translational Pharmacology in Drug Discovery
Authors:
- 24 November 2015
- journal article
- review article
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 7 (17) , 2351-2369
Abstract
In this perspective article, we explain how quantitative and translational pharmacology, when well-implemented, is believed to lead to improved clinical candidates and drug targets that are differentiated from current treatment options. Quantitative and translational pharmacology aims to build and continuously improve the quantitative relationship between drug exposure, target engagement, efficacy, safety and its interspecies relationship at every phase of drug discovery. Drug hunters should consider and apply these concepts to develop compounds with a higher probability of interrogating the clinical biological hypothesis. We offer different approaches to set an initial effective concentration or pharmacokinetic–pharmacodynamic target in man and to predict human pharmacokinetics that determine together the predicted human dose and dose schedule. All concepts are illustrated with ample literature examples.Keywords
This publication has 88 references indexed in Scilit:
- A General Network Pharmacodynamic Model–Based Design Pipeline for Customized Cancer Therapy Applied to the VEGFR PathwayCPT: Pharmacometrics & Systems Pharmacology, 2014
- Longitudinal Modeling of the Relationship Between Mean Plasma Glucose and HbA1c Following Antidiabetic TreatmentsCPT: Pharmacometrics & Systems Pharmacology, 2013
- Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and DevelopmentCPT: Pharmacometrics & Systems Pharmacology, 2013
- Effective visualization of integrated knowledge and data to enable informed decisions in drug development and translational medicineJournal of Translational Medicine, 2013
- Mechanism-Based Pharmacodynamic Modeling2012
- Evaluation of an Innovative Population Pharmacokinetic-Based Design for Behavioral Pharmacodynamic EndpointsThe AAPS Journal, 2012
- Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infectionJournal of Antimicrobial Chemotherapy, 2010
- A Randomized Experimental Investigation of Reasoning Training for People With DelusionsSchizophrenia Bulletin, 2009
- Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disordersJournal of Clinical Investigation, 2007
- Correlation betweenin vitroandin vivoconcentration–effect relationships of naproxen in rats and healthy volunteersBritish Journal of Pharmacology, 2006